First Episealer® Talus surgery in Asia performed
Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the ankle implant Episealer® Talus in Asia was performed on Friday. The company has previously communicated the scheduling of this surgery and can today provide additional information.
The surgery was performed by Dr. Wilson Li, Dr. MAN Shui-wah and Dr. Dennis Chan at the Queen Elizabeth Hospital in Hong Kong, assisted by Prof. Niek van Dijk, Clinical advisor to Episurf Medical, over video link.
“The implant sat perfectly well into the defect, thanks to the customised patient specific guide that fitted the anatomy precisely, and the whole instrumentation including the osteotomy guide was very user friendly. Great technical support from the Episurf team throughout the interactive preoperative 3D planning session and also intraoperative online feedback!” says Dr. Wilson Li.
“I am very proud of that this surgery could be performed, despite the challenges that the pandemic has created. I would like to congratulate Dr. Wilson Li and the team at Queen Elizabeth Hospital on this successful surgery. I would also like to extend my gratitude to the teams at Episurf and Pacific Medical Systems (Episurf’s distributor in Hong Kong) as well as Prof. van Dijk, for making this possible. We are looking forward to many more surgeries in Asia going forward” says Pål Ryfors, CEO Episurf Medical.
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] => <p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><strong><span style="font-size:10pt">About Episurf Medical</span></strong><br>
<em>Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.</em></p>
[HtmlContact:protected] => <p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><strong><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">For more information, please contact:</span></strong></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt;">Pål Ryfors, CEO, Episurf Medical<br /></span><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">Tel:</span><span style="font-size: 10pt;">+46 (0) 709 62 36 69<br /></span><span style="font-size: 10pt;">Email: </span><a href="mailto:pal.ryfors@episurf.com">pal.ryfors@episurf.com</a></p>
[HtmlTitle:protected] => <h1 style="line-height:120%;"><strong>First Episealer® Talus surgery in Asia performed </strong></h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the ankle implant Episealer® Talus in Asia was performed on Friday. The company has previously communicated the scheduling of this surgery and can today provide additional information.
The surgery was performed by Dr. Wilson Li, Dr. MAN Shui-wah and Dr. Dennis Chan at the Queen Elizabeth Hospital in Hong Kong, assisted by Prof. Niek van Dijk, Clinical advisor to Episurf Medical, over video link.
“The implant sat perfectly well into the defect, thanks to the customised patient specific guide that fitted the anatomy precisely, and the whole instrumentation including the osteotomy guide was very user friendly. Great technical support from the Episurf team throughout the interactive preoperative 3D planning session and also intraoperative online feedback!" says Dr. Wilson Li.
“I am very proud of that this surgery could be performed, despite the challenges that the pandemic has created. I would like to congratulate Dr. Wilson Li and the team at Queen Elizabeth Hospital on this successful surgery. I would also like to extend my gratitude to the teams at Episurf and Pacific Medical Systems (Episurf’s distributor in Hong Kong) as well as Prof. van Dijk, for making this possible. We are looking forward to many more surgeries in Asia going forward” says Pål Ryfors, CEO Episurf Medical.
[HtmlBody:protected] => <p style="margin-bottom: 11px; font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="line-height:107%">Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the ankle implant Episealer® Talus in Asia was performed on Friday. The company has previously communicated the scheduling of this surgery and can today provide additional information. </span></p>
<p style="margin-bottom: 11px; font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="line-height:107%">The surgery was performed by Dr. Wilson Li, Dr. MAN Shui-wah and Dr. Dennis Chan at the Queen Elizabeth Hospital in Hong Kong, assisted by Prof. Niek van Dijk, Clinical advisor to Episurf Medical, over video link. </span></p>
<p style="margin-bottom: 11px; font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="line-height:107%"><em><span style="color:black">“<span style="background-color:white">The implant sat perfectly well into the defect, thanks to the customised patient specific guide that fitted the anatomy precisely, and the whole instrumentation including the osteotomy guide was very user friendly. Great technical support from the Episurf team throughout the interactive preoperative 3D planning session and also intraoperative online feedback!"</span></span></em><span style="background-color:white"><span style="color:black"> says Dr. Wilson Li</span></span><span style="color:black">. </span></span></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><em><span style="line-height:107%"><span style="color:black">“I am very proud of that this surgery could be performed, despite the challenges that the pandemic has created. I would like to congratulate Dr. Wilson Li and the team at Queen Elizabeth Hospital on this successful surgery. I would also like to extend my gratitude to the teams at Episurf and Pacific Medical Systems (Episurf’s distributor in Hong Kong) as well as Prof. van Dijk, for making this possible. We are looking forward to many more surgeries in Asia going forward”</span></span></em><span><span style="line-height:107%"><span style="color:black"> says Pål Ryfors, CEO Episurf Medical.</span></span></span></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Twitter
[Name:protected] => Twitter
[Value:protected] => 9341
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => LinkedIn
[Name:protected] => LinkedIn
[Value:protected] => 12311
)
[2] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Facebook
[Name:protected] => Facebook
[Value:protected] => 9307
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] => About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
[Contact:protected] => For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
[Header:protected] =>
[Keywords:protected] => Array
(
[0] => Episurf Medical
[1] => EpiSurf
[2] => Pål Ryfors
[3] => Talus
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
[0] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] => 1
[MediaType:protected] => File
[Url:protected] => https://mb.cision.com/Main/14691/3301645/1383513.pdf
[FileName:protected] => wkr0006.pdf
[Title:protected] => First Episealer® Talus surgery in Asia performed
[Description:protected] => First Episealer® Talus surgery in Asia performed
[CreateDate:protected] => 2021-03-08T07:00:30.753Z
[Keywords:protected] => Array
(
)
[Extension:protected] => pdf
)
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 3910764
[EncryptedId:protected] => B4A778A0C3225952
[IsRegulatory:protected] =>
[PublishDate:protected] => 2021-03-08T07:00:00Z
[LastChangeDate:protected] => 2021-03-08T07:00:30.72Z
[Title:protected] => First Episealer® Talus surgery in Asia performed
[Intro:protected] =>
[IptcCode:protected] => 04016003
[InformationType:protected] => PRM
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/first-episealer--talus-surgery-in-asia-performed,c3301645
[LanguageVersions:protected] => Array
(
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)